Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Positive Association Between Ultrasonographic Fatty Liver Indicator and the Severity of Coronary Artery Disease

NCT06541132 is registered in ClinicalTrials.gov with Chongqing Medical University as lead sponsor.

NCT NCT06541132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06541132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Positive Association Between Ultrasonographic Fatty Liver Indicator and the Severity of Coronary Artery Disease
Lead sponsor
Chongqing Medical University
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2022
Completion date
April 28, 2025
Enrollment
190 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease of significant bypass graft, metabolic dysfunction-associated fatty liver disease, syntax score, ultrasonography